中西医结合疗法治疗急性胰腺炎临床观察  

Clinical observation on treatment of acute pancreatitis by TCM combined with western medicine

作　　者：孔婧[1] 王晓素[1] 周秉舵[1] 姜清宇[1] 李英[1] 

机构地区：[1]上海中医药大学附属岳阳中西医结合医院消化科,上海200437

出　　处：《上海中医药杂志》2015年第12期39-41,共3页Shanghai Journal of Traditional Chinese Medicine

基　　金：上海市教委重点学科资助项目(J50305);上海市教委科研创新项目(14YZ065);国家自然科学基金青年基金项目(81302929)

摘　　要：目的观察中西医结合疗法治疗急性胰腺炎的临床疗效。方法将65例急性胰腺炎患者随机分为治疗组(32例)与对照组(33例)。对照组予常规西药治疗,治疗组在对照组治疗措施基础上加服清下化瘀方。两组疗程均为7天,观察临床疗效与并发症情况,比较C-反应蛋白、血钙水平以及胰腺CT评分的变化情况。结果 1治疗组、对照组临床总有效率分别为96.88%和84.85%;组间临床疗效比较,差异有统计学意义(P<0.05)。2组间治疗后比较,CRP与Ca2+水平差异有统计学意义(P<0.05)。3组间治疗后比较,胰腺CT评分差异有统计学意义(P<0.05)。4两组并发症发生率比较,差异有统计学意义(P<0.05)。结论中西医结合疗法治疗急性胰腺炎的疗效满意,可减轻全身炎症反应,降低并发症发生率。Objective To evaluate clinical effects and prognosis of ＂Qingxia Huayu Decoction＂ combined with Western Medicine on AP treatment; Methods 65 cases of acute pancreatitis patients were divided into treatment group （32 cases ） and control group （33 cases）. Patients in the control group took western medicine treatment, and the treatment group took ＂Qingxia Huayu Decoction＂ on the basis of the treatment of the control group for 7 days, respectively. CT score and CRP, calcium,the complication rate were analyzed, The clinical effects of these two groups would be evaluated. Results （1） The clinical study showed that the total effective rate of the treatment and control groups were 96, 88% and 84.85% respectively; there was significant difference in the clinical efficacy between the two groups（P 〈 0.05）. （2）There was significant difference in the level of CRP and Ca2＋ between the two groups after the treatment （P 〈 0.05 ）. （3）There was significant difference in the CT score between the two groups after the treatment（ P 〈 0.05 ）. （4）There was significant difference in the complication rate in the two groups （P 〈 0.05 ）. Conclusion There are well clinical and synergies of ＂ Qingxia Huayu Decoction＂ combined with western medicine on SAP, and it play a good role to improve the prognosis of severe acute pancreatitis.

关 键 词：急性胰腺炎 清下化瘀方 中西医结合疗法 炎症反应 并发症 

分 类 号：R576[医药卫生—消化系统]